Technical Analysis for CGS - CogState Limited  

Grade Last Price % Change Price Change
A 1.400 -0.36% -0.005
CGS closed down 0.36 percent on Wednesday, May 1, 2024, on 47 percent of normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Earnings due: May 9
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
200 DMA Support Bullish 0.00%
Upper Bollinger Band Walk Strength 0.00%
Overbought Stochastic Strength 0.00%
200 DMA Support Bullish -0.36%
Pocket Pivot Bullish Swing Setup -0.36%
Spinning Top Other -0.36%
Upper Bollinger Band Walk Strength -0.36%
Above Upper BB Strength -0.36%
Gapped Up Strength -0.36%
Overbought Stochastic Strength -0.36%

   Recent Intraday Alerts

Alert Time
Fell Below Previous Day's Low about 9 hours ago
Down 2% about 9 hours ago
Down 1% about 9 hours ago
Fell Below Upper Bollinger Band about 9 hours ago
Fell Below 200 DMA about 9 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

CogState Limited   Description

Cogstate Limited is a cognitive science company delivering software and services. The Company's segments include cognitive testing in Clinical Trials; the precision recruitment market, the healthcare market, the sport market and administration. In the clinical trials market, the Company's technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. In the precision recruitment market, the technology is used as an online screening tool as part of the process of recruiting subjects in clinical trials. In the healthcare market, the technology and associated services are being developed as a tool for primary care physicians to assess cognitive decline. In the sport market, the technology and associated services are used to provide concussion management tools in sport.


Classification

Sector: Technology
Industry: Health Information Services
Keywords: Health Software Healthcare Pharmaceutical Biotechnology Disease Drugs Clinical Trial Recruitment Pharmaceutical Industry Screening Drug Discovery Biotechnology Companies Healthcare Market Primary Care Clinical Research Concussion

Is CGS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 1.87
52 Week Low 1.125
Average Volume 106,487
200-Day Moving Average 1.391
50-Day Moving Average 1.273
20-Day Moving Average 1.312
10-Day Moving Average 1.325
Average True Range 0.050
RSI (14) 61.83
ADX 34.31
+DI 39.630
-DI 14.066
Chandelier Exit (Long, 3 ATRs) 1.291
Chandelier Exit (Short, 3 ATRs) 1.379
Upper Bollinger Bands 1.411
Lower Bollinger Band 1.214
Percent B (%b) 0.95
BandWidth 14.997
MACD Line 0.030
MACD Signal Line 0.018
MACD Histogram 0.0121
Fundamentals Value
Market Cap 238.19 Million
Num Shares 170 Million
EPS -0.02
Price-to-Earnings (P/E) Ratio -66.67
Price-to-Sales 4.50
Price-to-Book 7.06
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.453
Resistance 3 (R3) 1.447 1.423 1.444
Resistance 2 (R2) 1.423 1.410 1.426 1.441
Resistance 1 (R1) 1.412 1.402 1.418 1.418 1.438
Pivot Point 1.388 1.388 1.391 1.391 1.388
Support 1 (S1) 1.377 1.375 1.383 1.383 1.362
Support 2 (S2) 1.353 1.367 1.356 1.359
Support 3 (S3) 1.342 1.353 1.356
Support 4 (S4) 1.348